Release of tumor necrosis factor-alpha and prostanoids in whole blood cultures after in vivo exposure to low-dose aspirin.

BACKGROUND: The preventive effect of low-dose aspirin in cardiovascular disease is generally attributed to its antiplatelet action caused by differential inhibition of platelet cyclooxygenase-1. However, there is evidence that aspirin also affects release of inflammatory cytokines, including tumor n...

Descripción completa

Detalles Bibliográficos
Autores principales: Beckmann, I, Ben-Efraim, S, Vervoort, M, Wallenburg, H C
Formato: Texto
Lenguaje:English
Publicado: 2001
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781693/
https://www.ncbi.nlm.nih.gov/pubmed/11405554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781693/
https://www.ncbi.nlm.nih.gov/pubmed/11405554

Ejemplares similares